CN114502575A - 用于arsa基因转移的腺相关病毒组合物和其使用方法 - Google Patents
用于arsa基因转移的腺相关病毒组合物和其使用方法 Download PDFInfo
- Publication number
- CN114502575A CN114502575A CN202080054069.6A CN202080054069A CN114502575A CN 114502575 A CN114502575 A CN 114502575A CN 202080054069 A CN202080054069 A CN 202080054069A CN 114502575 A CN114502575 A CN 114502575A
- Authority
- CN
- China
- Prior art keywords
- amino acid
- seq
- capsid protein
- protein corresponding
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06001—Arylsulfatase (3.1.6.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Psychiatry (AREA)
- Environmental Sciences (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962859539P | 2019-06-10 | 2019-06-10 | |
| US62/859,539 | 2019-06-10 | ||
| US201962866374P | 2019-06-25 | 2019-06-25 | |
| US62/866,374 | 2019-06-25 | ||
| US201962915523P | 2019-10-15 | 2019-10-15 | |
| US62/915,523 | 2019-10-15 | ||
| US202062960487P | 2020-01-13 | 2020-01-13 | |
| US62/960,487 | 2020-01-13 | ||
| US202062987858P | 2020-03-10 | 2020-03-10 | |
| US62/987,858 | 2020-03-10 | ||
| US202063010970P | 2020-04-16 | 2020-04-16 | |
| US63/010,970 | 2020-04-16 | ||
| PCT/US2020/036846 WO2020251954A1 (en) | 2019-06-10 | 2020-06-09 | Adeno-associated virus compositions for arsa gene transfer and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114502575A true CN114502575A (zh) | 2022-05-13 |
Family
ID=73782242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080054069.6A Pending CN114502575A (zh) | 2019-06-10 | 2020-06-09 | 用于arsa基因转移的腺相关病毒组合物和其使用方法 |
Country Status (15)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2769577C1 (ru) * | 2021-06-01 | 2022-04-04 | федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) | Препарат для лечения метахроматической лейкодистрофии и способ ее лечения |
| CN119213120A (zh) * | 2022-05-16 | 2024-12-27 | 建新公司 | 治疗异染性脑白质营养不良的方法 |
| MA71631A (fr) | 2022-07-29 | 2025-05-30 | Regeneron Pharmaceuticals, Inc. | Particules virales reciblées vers le récepteur 1 de transferrine |
| WO2024036250A2 (en) * | 2022-08-10 | 2024-02-15 | Homology Medicines, Inc. | Adeno-associated virus compositions for arsa gene transfer and methods of use thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106661591A (zh) * | 2014-05-02 | 2017-05-10 | 建新公司 | 用于视网膜及cns基因疗法的aav载体 |
| CN107532177A (zh) * | 2015-03-24 | 2018-01-02 | 加利福尼亚大学董事会 | 腺相关病毒变体及其使用方法 |
| US20180021364A1 (en) * | 2015-01-16 | 2018-01-25 | Voyager Therapeutics, Inc. | Central nervous system targeting polynucleotides |
| CN107828820A (zh) * | 2010-10-27 | 2018-03-23 | 学校法人自治医科大学 | 用于向神经系统细胞导入基因的腺相关病毒粒子 |
| CN108367055A (zh) * | 2015-05-15 | 2018-08-03 | 明尼苏达大学董事会 | 用于治疗性递送到中枢神经系统的腺相关物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9839696B2 (en) * | 2010-04-30 | 2017-12-12 | City Of Hope | Recombinant adeno-associated vectors for targeted treatment |
| EP3929287A3 (en) * | 2015-06-18 | 2022-04-13 | The Broad Institute, Inc. | Crispr enzyme mutations reducing off-target effects |
| WO2019152841A1 (en) * | 2018-02-01 | 2019-08-08 | Homology Medicines, Inc. | Adeno-associated virus compositions for pah gene transfer and methods of use thereof |
| CA3129321A1 (en) * | 2019-02-15 | 2020-08-20 | Generation Bio Co. | Modulation of rep protein activity in closed-ended dna (cedna) production |
| JP7715640B2 (ja) * | 2019-05-03 | 2025-07-30 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 異染性白質ジストロフィーの治療に有用な組成物 |
-
2020
- 2020-06-09 PE PE2021002049A patent/PE20220233A1/es unknown
- 2020-06-09 MX MX2021015076A patent/MX2021015076A/es unknown
- 2020-06-09 TW TW109119333A patent/TW202112807A/zh unknown
- 2020-06-09 KR KR1020227000707A patent/KR20220035107A/ko not_active Ceased
- 2020-06-09 BR BR112021024855A patent/BR112021024855A2/pt not_active IP Right Cessation
- 2020-06-09 WO PCT/US2020/036846 patent/WO2020251954A1/en not_active Ceased
- 2020-06-09 EP EP20821636.6A patent/EP3980447A4/en not_active Withdrawn
- 2020-06-09 JP JP2021573242A patent/JP2022536338A/ja active Pending
- 2020-06-09 CN CN202080054069.6A patent/CN114502575A/zh active Pending
- 2020-06-09 CA CA3142932A patent/CA3142932A1/en active Pending
- 2020-06-09 AU AU2020292256A patent/AU2020292256B2/en not_active Ceased
-
2021
- 2021-12-09 IL IL288863A patent/IL288863A/en unknown
- 2021-12-10 CL CL2021003295A patent/CL2021003295A1/es unknown
- 2021-12-10 US US17/643,631 patent/US20220204991A1/en not_active Abandoned
- 2021-12-10 CO CONC2021/0016797A patent/CO2021016797A2/es unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107828820A (zh) * | 2010-10-27 | 2018-03-23 | 学校法人自治医科大学 | 用于向神经系统细胞导入基因的腺相关病毒粒子 |
| CN106661591A (zh) * | 2014-05-02 | 2017-05-10 | 建新公司 | 用于视网膜及cns基因疗法的aav载体 |
| US20180021364A1 (en) * | 2015-01-16 | 2018-01-25 | Voyager Therapeutics, Inc. | Central nervous system targeting polynucleotides |
| CN107532177A (zh) * | 2015-03-24 | 2018-01-02 | 加利福尼亚大学董事会 | 腺相关病毒变体及其使用方法 |
| CN108367055A (zh) * | 2015-05-15 | 2018-08-03 | 明尼苏达大学董事会 | 用于治疗性递送到中枢神经系统的腺相关物 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020292256A1 (en) | 2022-01-06 |
| IL288863A (en) | 2022-02-01 |
| US20220204991A1 (en) | 2022-06-30 |
| BR112021024855A2 (pt) | 2022-05-03 |
| TW202112807A (zh) | 2021-04-01 |
| EP3980447A1 (en) | 2022-04-13 |
| KR20220035107A (ko) | 2022-03-21 |
| PE20220233A1 (es) | 2022-02-07 |
| CA3142932A1 (en) | 2020-12-17 |
| JP2022536338A (ja) | 2022-08-15 |
| MX2021015076A (es) | 2022-06-02 |
| CO2021016797A2 (es) | 2022-01-17 |
| AU2020292256B2 (en) | 2023-01-19 |
| WO2020251954A1 (en) | 2020-12-17 |
| EP3980447A4 (en) | 2023-07-26 |
| CL2021003295A1 (es) | 2022-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020260491B2 (en) | Gene therapies for lysosomal disorders | |
| AU2020205228B2 (en) | Gene therapies for lysosomal disorders | |
| AU2023214366B2 (en) | Gene therapies for lysosomal disorders | |
| KR20220006527A (ko) | 리소좀 장애에 대한 유전자 요법 | |
| AU2020292256B2 (en) | Adeno-associated virus compositions for ARSA gene transfer and methods of use thereof | |
| KR20230066360A (ko) | 신경퇴행성 장애를 위한 유전자 요법 | |
| KR20210150486A (ko) | 리소좀 장애에 대한 유전자 요법 | |
| KR20230051529A (ko) | 리소좀 장애에 대한 유전자 요법 | |
| AU2018387826B2 (en) | Constructs comprising neuronal viability factors and uses thereof | |
| CN102127546B (zh) | 一种骨骼肌特异性actin启动子及其应用 | |
| HK40048832A (en) | Gene therapies for lysosomal disorders | |
| HK40046514A (en) | Gene therapies for lysosomal disorders | |
| HK40048832B (en) | Gene therapies for lysosomal disorders | |
| HK40047428A (en) | Gene therapies for lysosomal disorders | |
| HK40067825A (zh) | 用於溶酶体障碍的基因疗法 | |
| CN114025806A (zh) | 用于溶酶体障碍的基因疗法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220513 |
|
| WD01 | Invention patent application deemed withdrawn after publication |